Involvement of the appendix in a relapsed case of primary nasal NK/T-cell lymphoma

Leukemia and Lymphoma

Volumn 37, Issue 5-6, 2000, Pages 633-634

  Tsujimura, Hideki ^a   Takagi, Toshiyuki ^a   Tamaru, Jun Ichi ^b   Sakai, Chikara ^a  

^a CHIBA CANCER CENTER   (Japan)

^b CHIBA UNIVERSITY   (Japan)

Author keywords

Acute appendicitis; Appendectomy; Appendiceal involvement; Nasal NK T cell lymphoma

Indexed keywords

CYCLOPHOSPHAMIDE; ETOPOSIDE; RANIMUSTINE; ANTINEOPLASTIC AGENT; BLEOMYCIN; CISPLATIN; CYTARABINE; DOXORUBICIN; ESAP PROTOCOL; FOLINIC ACID; MACOP B PROTOCOL; MACOP-B PROTOCOL; METHOTREXATE; METHYLPREDNISOLONE; NITROSOUREA DERIVATIVE; PREDNISONE; VINCRISTINE;

ACUTE APPENDICITIS; ADULT; APPENDIX CANCER; ARTICLE; CANCER CHEMOTHERAPY; CASE REPORT; HISTOPATHOLOGY; HUMAN; MALE; NATURAL KILLER CELL; NOSE CANCER; NOSE LYMPHOMA; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION; T CELL LYMPHOMA; APPENDECTOMY; APPENDICITIS; APPENDIX TUMOR; INTESTINE PERFORATION; METASTASIS; MULTIMODALITY CANCER THERAPY; NOSE TUMOR; PATHOLOGY; SKIN TUMOR; SPLEEN TUMOR; VIRUS INFECTION;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; APPENDECTOMY; APPENDICEAL NEOPLASMS; APPENDICITIS; BLEOMYCIN; CISPLATIN; COMBINED MODALITY THERAPY; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; EPSTEIN-BARR VIRUS INFECTIONS; ETOPOSIDE; HUMANS; INTESTINAL PERFORATION; KILLER CELLS, NATURAL; LEUCOVORIN; LYMPHOMA, T-CELL; MALE; METHOTREXATE; METHYLPREDNISOLONE; NITROSOUREA COMPOUNDS; NOSE NEOPLASMS; PREDNISONE; SKIN NEOPLASMS; SPLENIC NEOPLASMS; TUMOR VIRUS INFECTIONS; VINCRISTINE;

EID: 0034006688     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428190009058518     Document Type: Article

References (9)

1. Mori, M., Kusunoki, T., Kikuchi, M., Motoori, T. and Sugimachi, K. (1985). Primary malignant lymphoma of the appendix. Japanese Journal of Surgery, 15, 230-3.
2. Pasquale, M.D., Shabahang, M., Bitterman, P., Lack, E.E. and Evans, S.R. (1994). Primary lymphoma of the appendix: case report and review of the literature. Surgical Oncology, 3, 243-8.
3. Muller, G., Dargent, J.L., Duwel, V., D'Olne, D., Vanvuchelen, J., Haot, J. and Hustin, J. (1997). Leukemia and lymphoma of the appendix presenting as acute appendicitis or acute abdomen: four case reports with a review of the literature. Journal of Cancer Research and Clinical Oncology, 123, 560-4.
4. Harris, N.L., Jaffe, E.S., Stein, H., Banks, P.M., Chan, J.K.C., Cleary, M.L., Delsol, G., De Wolf-Peeters, C., Falini, B., Gatter, K.C., Grogan, T.M., Isaacson, PG., Knoules, D.M., Mason, D.Y., Muller-Hermelink, H.K., Pileri, S.A., Piris, M.A., Ralfkiaer, E. and Warnke, R.A. (1994). A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood, 84, 1361-92.
5. Weick, J.K., Dahlberg, S., Fisher, R.I., Dana, B., Miller, T.P., Balcerzak, S.P. and Pierce, H.I., (1991). Combination chemotherapy of intermediate-grade and high-grade non-Hodgkin's lymphoma with MACOP-B: a Southwest Oncology Group study. Journal of Clinical Oncology, 9, 748-53.
6. Valasquez, W.S., McLaughlin, P., Tucker, S., Hagemeister, F.B., Swan, F., Rodriguez, M.A., Romaguera, J., Rubenstein, E. and Cabanillas, F. (1994). ESHAP An effective chemotherapy regimen in refractory and relapsing lymphoma: a 4-year follow up study. Journal of Clinical Oncology, 12, 1169-76.
7. Chan, J.K.C., Sin, V.C., Wong, K.F., Ng, C.S., Tsang, W.Y., Chan, C.H., Cheung, M.M. and Lau, W.H. (1997). Nonnasal lymphoma expressing the natural killer marker CD56: a clinocopathological study of an uncommon aggressive neoplasm. Blood, 89, 4501-13.
8. Cheung, M.M.C., Chan, J.K.C., Lau, W.H., Foo, W., Chan, P.T., Ng, C.S. and Ngan, R.K. (1998). Primary non-Hodgkin's lymphoma of the nose and nasopharynx: clinical features, tumor immunophenotype, and treatment outcome in 113 patients. Journal of Clinical Oncology, 16, 70-7.
9. Kern, W.F., Spier, C.M., Hanneman, E.H., Miller, T.P., Matzner, M. and Grogan, T.M. (1992). Neural cell adhesion molecule-positive peripheral T-cell lymphoma: A rare variant with a propensity for unusual sites of involvement. Blood, 79, 2432-37.